GILD

NASD Gilead Sciences, Inc.

Oct 23, 2026 · 7:33 PM ET LAST TRADE Market Closed

$156.31 ↑ +0.27 (+0.17%) Trading Up from the previous close of $156.04, $1.34 below the day’s high of $157.65

YTD change: +27.35%
vs 20-day SMA: +3.67%
vs 200-day SMA: +12.69%

Price ranges

Previous day

$153.00 $157.42

open $154.24 close $157.19

+$2.95 (+1.91%)

Today

$155.76 $157.65

open $156.47 now $156.31

-$0.16 (-0.10%)

Past week

$151.71 $157.58

from $157.37 now $156.31

-$1.06 (-0.67%)

Past month

$142.60 $160.51

from $149.69 now $156.31

+$6.62 (+4.42%)

This year

$116.88 $160.51

from $122.74 now $156.31

+$33.57 (+27.35%)

Price & Performance

+23.55 (+17.62%) / 6M

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Very Good

The stock is 2.6% away from all-time highs of $160.51
GILD is up 27% since the beginning of the year
GILD is up 29% over the past 12 months
GILD is up 4% over the past 1 month
2% of all GILD investors are betting against GILD

GILD reads very good: price sits above both the 20- and 200-day averages, the 12-month move is +30.2%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No

EPS $-6.75

Earnings momentum +409.4% Quarterly EPS growth

Quarterly change +409.4%

Valuation

P/E ratio N/A

Enterprise value $216.7B

Beta 0.05

Balance sheet & scale

IncomeN/A

Revenue$30.5B

Cash$4.9B

Debt$26.2M

Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD

Sector Manufacturing

Sub Sector Chemical Manufacturing

Market cap $193.8B

Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm's primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases. It offers antiviral products under Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi, and Vosevi brands. The company was founded by Michael L. Riordan on June 22, 1987 and is headquartered in Foster City, CA.

Competitor comparison

Ticker	Company	Price	Change
LLY	Eli Lilly and Company	$1,306.69	+2.83%
JNJ	Johnson & Johnson	$267.61	+3.81%
ABBV	AbbVie, Inc.	$285.19	+0.14%
MRK	Merck & Co., Inc.	$147.24	-1.76%
RHHBY	Roche Holding Ltd Sponsored ADR	$59.62	+0.86%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.